The Asian steelmaker said November 2 that internal disputes amongst Japanese companies would hurt the country during a time of market uncertainty and a shift toward carbon neutrality.
The purpose of the project is to help pharmaceutical manufacturers achieve sustainability and environmental goals in order to reduce their Scope 3 emissions.
The report suggests the U.S. is in for an extended period of perhaps a decade or more of change regarding how supply chains for semiconductors are designed and executed.